Physician profile
Vikram S Pole
NPI 1033568647
$463.77
in general payments reported to CMS, 2019-2025
9 companies · $165 in 2025
The $165 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $32.52 · 2021: $48.89 · 2022: $133 · 2023: $28.97 · 2024: $54.93 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152 · Education: $97.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $151.90 |
| Education | $97.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $114.30 | 2020-2023 | Itero Element 5d |
| Straumann USA LLC | $101.46 | 2021-2022 | |
| Hu-Friedy Mfg. Co., LLC | $97.20 | 2025 | |
| Biohorizons Implant Systems INC. | $68.00 | 2025 | Biohorizons Dental Implants |
| Philips North America LLC | $30.01 | 2024 | (3110) Oral Health Care Und, (L00) Whitening |
| Orapharma, A Division of Bausch Health US, LLC | $16.13 | 2023 | Arestin |
| Envista Holdings Corporation | $13.12 | 2024 | Nexus Rmgi |
| Ultradent Products INC | $11.80 | 2024 | |
| Dentsply Sirona INC | $11.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Pole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.